A UK research team has developed a pioneering blood test that could change the way lung cancer is detected and monitored.
New trials highlight Pathlight’s performance in the neoadjuvant triple-negative breast cancer (TNBC) settingMORRISVILLE, N.C.--(BUSINESS WIRE)--#BreastCancer--SAGA Diagnostics®, a pioneer in ...
A large international study has shown that a blood biomarker yet to be used in cardiac arrest care can give a clearer picture ...
A team of UK researchers has developed a pioneering blood test that could enable doctors to detect and monitor lung cancer in ...
UK researchers have developed a blood test capable of detecting and monitoring lung cancer in real time using infrared ...
Dark mode beat light in a B2B SaaS test even with lower CTR – showing how audience context and industry cues shape ...
Laptops quietly monitor their own health, but most people never tap into the tools that can warn of trouble long before a crash or data loss. Built-in hardware diagnostics sit below the operating ...
Researchers developed a blood test that spots ALS with 90% accuracy. The 46-gene panel could cut diagnostic delays that now ...